{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:06:19Z","timestamp":1772795179698,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jacl.2015.12.009","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T13:10:47Z","timestamp":1450789847000},"page":"323-329.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Quality of life in patients treated with lipoprotein apheresis"],"prefix":"10.1016","volume":"10","author":[{"given":"Adrian","family":"Rosada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Kassner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Banisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2015.12.009_bib1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0021-9150(96)06030-3","article-title":"Ten-year follow-up results from the Goettingen Risk, Incidence and Prevalence Study (GRIPS). I. Risk factors for myocardial infarction in a cohort of 5790 men","volume":"129","author":"Cremer","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2015.12.009_bib2","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/01.CIR.77.6.1238","article-title":"Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients","volume":"77","author":"Hoff","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.12.009_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1744-9987.2009.00667.x","article-title":"Single lipoprotein apheresis session improves cardiac microvascular function in patients with elevated lipoprotein(a): detection by stress\/rest perfusion magnetic resonance imaging","volume":"13","author":"Bohl","year":"2009","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jacl.2015.12.009_bib4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2015.12.009_bib5","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMe1507041","article-title":"Proof That Lower Is Better\u2013LDL Cholesterol and IMPROVE-IT","volume":"372","author":"Jarcho","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2015.12.009_bib6","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2015.12.009_bib7","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/CIRCULATIONAHA.113.002432","article-title":"Lipoprotein apheresis in patients with maximally tolerated lipid-lowering therapy, lipoprotein(a)-hyperlipoproteinemia, and progressive cardiovascular disease: prospective observational multicenter study","volume":"128","author":"Leebmann","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2015.12.009_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/aor.12135","article-title":"Does regular lipid apheresis in patients with isolated elevated lipoprotein(a) levels reduce the incidence of cardiovascular events?","volume":"38","author":"Rosada","year":"2014","journal-title":"Artif Organs"},{"key":"10.1016\/j.jacl.2015.12.009_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2362.1989.tb00223.x","article-title":"Effect of HELP-LDL-apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post-treatment return to baseline levels","volume":"19","author":"Armstrong","year":"1989","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jacl.2015.12.009_bib10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0026-0495(98)90278-5","article-title":"Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis","volume":"47","author":"Banyai","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.jacl.2015.12.009_bib11","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2015.12.009_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ncpcardio1456","article-title":"Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events","volume":"6","author":"Jaeger","year":"2009","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.jacl.2015.12.009_bib13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/039139880202501210","article-title":"Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP","volume":"25","author":"Julius","year":"2002","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jacl.2015.12.009_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1526-0968.1999.00154.x","article-title":"Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: a long-term evaluation","volume":"3","author":"Richter","year":"1999","journal-title":"Ther Apher"},{"key":"10.1016\/j.jacl.2015.12.009_bib15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0277-9536(95)00115-N","article-title":"German translation and psychometric testing of the SF-36 Health Survey: preliminary results from the IQOLA Project. International Quality of Life Assessment","volume":"41","author":"Bullinger","year":"1995","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jacl.2015.12.009_bib16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jacl.2015.12.009_bib17","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0272-6386(03)00361-5","article-title":"Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients","volume":"41","author":"Lowrie","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jacl.2015.12.009_bib18","first-page":"689","article-title":"[The Beck Depression Inventory in clinical practice]","volume":"62","author":"Hautzinger","year":"1991","journal-title":"Nervenarzt"},{"key":"10.1016\/j.jacl.2015.12.009_bib19","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1046\/j.1523-1755.2000.00059.x","article-title":"Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients","volume":"57","author":"Kimmel","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.jacl.2015.12.009_bib20","series-title":"Der SF-36-Fragebogen zum Gesundheitszustand: Handbuch f\u00fcr die deutschsprachige Fragebogenversion","author":"Bullinger","year":"1998"},{"key":"10.1016\/j.jacl.2015.12.009_bib21","article-title":"Der SF-36 im Bundes-Gesundheitssurvey - Beschreibung einer aktuellen Normstichprobe","volume":"61","author":"Ellert","year":"1999","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.jacl.2015.12.009_bib22","series-title":"Beck-Depressions-Inventar (BDI), Testhandbuch","author":"Hautzinger","year":"1995"},{"key":"10.1016\/j.jacl.2015.12.009_bib23","article-title":"Der SF-36 \u2014 Ein Instrument zur Messung der Lebensqualit\u00e4t von Populationen: M\u00f6glichkeiten und Grenzen","volume":"61","author":"Radoschewski","year":"1999","journal-title":"Gesundheitswesen"},{"key":"10.1016\/j.jacl.2015.12.009_bib24","first-page":"889","article-title":"Measuring disease-specific quality of life in clinical trials","volume":"134","author":"Guyatt","year":"1986","journal-title":"CMAJ"},{"key":"10.1016\/j.jacl.2015.12.009_bib25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-118-8-199304150-00009","article-title":"Measuring health-related quality of life","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2015.12.009_bib26","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0002-9343(86)90811-9","article-title":"Removal of low-density lipoproteins in patients by extracorporeal immunoadsorption","volume":"80","author":"Saal","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.jacl.2015.12.009_bib27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(75)92193-5","article-title":"Plasma exchange in the management of homozygous familial hypercholesterolaemia","volume":"1","author":"Thompson","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.jacl.2015.12.009_bib28","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacl.2012.03.004","article-title":"Apheresis in homozygous familial hypercholesterolemia: the results of a follow-up of all Norwegian patients with homozygous familial hypercholesterolemia","volume":"6","author":"Graesdal","year":"2012","journal-title":"J Clin Lipidol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415004705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287415004705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T17:31:41Z","timestamp":1567445501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287415004705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1933287415004705"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2015.12.009","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of life in patients treated with lipoprotein apheresis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}